Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Heimstaden AB and Folksam Group Increase Equity Commitments

On 26 September 2021 Heimstaden Bostad announced buying Akelius’ German, Swedish and Danish properties and a related SEK 24.8 billion equity raise from existing owners. Heimstaden AB and the Folksam Group (through Folksam Liv and Folksam Sak) have decided to increase their equity injections; Heimstaden will invest an additional SEK 3.7 billion, for a total investment of SEK 12.2 billion, and the Folksam Group will invest an additional SEK 2.75 billion for a total investment of SEK 10.75 billion. “We appreciate the continued support of our investors, which will further strengthen our

Paula da Silva replaces Lars Sjögren as CEO of P27

The Board of P27 has appointed Paula da Silva as new CEO of P27 replacing Lars Sjögren. Paula will start on January 17 2022, while Claus Richter, deputy CEO of P27, will take the interim CEO role as of today until Paula joins.The recent EU Commission merger approval marked an important milestone for P27. With that, P27 is moving into a new phase with focus on executing on the plans to bring the Nordic payment infrastructure to market. ”We are very pleased that Paula has accepted the position as new CEO of P27. Paula is bringing a long track record of successful transformation journeys as

Heimstaden Increases Equity Commitment to Heimstaden Bostad to SEK 12.2 billion

On 26 September 2021 Heimstaden Bostad announced buying Akelius’ German, Swedish and Danish properties and a related SEK 24.8 billion equity raise, of which Heimstaden committed SEK 8.5 billion. Heimstaden has decided to increase its equity injection by SEK 3.7 billion, bringing the total investment to SEK 12.2 billion. The investment will be financed with SEK 8.2 billion in cash at hand and a committed 2-year bridge financing facility. “We are pleased to increase our investment, which will contribute to preserving our ownership position and support the the continued financial

Caverion acquires Bott Kälte- und Klimatechnik, cooling and air conditioning specialist in Wiesbaden, Germany

Caverion Corporation Investor news 29 October 2021 at 10.00 a.m. EESTCaverion acquires Bott Kälte- und Klimatechnik, cooling and air conditioning specialist in Wiesbaden, Germany Caverion has today closed an agreement to acquire the business of Bott Kälte- und Klimatechnik (“Bott”) in Germany. Bott is a small cooling and air conditioning specialist based in Wiesbaden, Germany. Through the acquisition, Caverion supports its growth strategy and strengthens its market position in smart technologies. Bott operates in the Frankfurt area. The Caverion Frankfurt branch has

Interim Report January-September 2021

Order intake was MSEK 1,895 (1,664), an increase of +13.9% adjusted to +14.5% for currency effects of MSEK -7, acquisitions of MSEK +3 and disposals of MSEK -5.The third quarter: · Order intake was MSEK 1,895 (1,664), an increase of +13.9% adjusted to +14.5% for currency effects of MSEK -7, acquisitions of MSEK +3 and disposals of MSEK -5 · Net sales were MSEK 1,745 (1,700), an increase of +2.6% adjusted to +3.7% for currency effects of MSEK -5, acquisitions of MSEK +4 and disposals of MSEK -16 · Operating profit was MSEK 184.2 (66.8), an increase of +175,7% with an operating

Contract for CSV Normand Samson

Solstad Offshore ASA is pleased to announce that a major oil service company has chartered the CSV Normand Samson for a period of minimum 350 days with options to extend with additional 150 days. The contract will commence during Q2 2022. The vessel will be utilized on a field development project in South America. Skudeneshavn October 29[th], 2021 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad Offshore ASAwww.solstad.com

BioStock: Evaxion Biotech to test EVX-01 in collaboration with Merck & Co.

Copenhagen-based Evaxion Biotech runs several projects based on its proprietary AI drug discovery platform. The main candidate EVX-01 is developed as a combination therapy with checkpoint inhibitors. A phase IIb trial is planned to start this winter, in which EVX-01 will be combined with blockbuster drug Keytruda after a recent collaboration agreement between Evaxion and Merck & Co. subsidiary MSD.Read the full article at biostock.se:https://www.biostock.se/en/2021/10/evaxion-biotech-to-test-evx-01-in-collaboration-with-merck-co/This is a press release from BioStock - Connecting

Large Flowscape customer continues global rollout

A large global company continues the rollout of Flowscape's smart office solution. This customer installation today comprises more than 65,000 bookable work desks and 7,800 meeting rooms in 47 countries. This additional order for the increased number of user licenses and installation services reaches SEK 1,1 million (110,000 euro) during the first year.“With more than 65,000 bookable work desks and 7,800 meeting rooms, this customer installation is probably the most comprehensive in the world. This prove that the Flowscape system is able to handle very large installations in an efficient

Change in number of shares outstanding in Sectra AB during October

Linköping, Sweden – October 29, 2021 – During October, the number of shares outstanding in the medical imaging IT and cybersecurity company Sectra  (STO: SECT B) increased by 13,103,460 Class A redemption shares and 179,524,010 Class B redemption shares. As of October 29, 2021, the number of shares totals 385,254,940.The change is attributable to Sectra’s 2021 share redemption program. Each redemption share will automatically be redeemed for a cash consideration of SEK 0.90 per redemption share. Record day for redemption of redemption shares is November 2 and

Interim Report, January - September 2021

Period July 1 – September 30, 2021 · Net sales of SEK 106 m (96 m) · Recurring revenues of SEK 70 m (63 m) · which corresponds to % of net sales 66 % (66 %) · EBITDA SEK 30 m (27 m) · EBITDA margin 28 % (28 %) · EBIT 17 m (14 m) · EBIT margin 16 % (15 %) · Net profit SEK 12 m (9 m) · Net profit margin 12 % (10 %) · EPS before dilution SEK 0.23 (0.17) · Cash flow from operating activities SEK 30 m (3 m) · ACV SEK 9.4 m (4.3 m) · ARR SEK 291 m (259 m) Period January 1 – September 30, 2021 · Net sales of SEK 351 m (300 m) · Recurring revenues

Aptahem announces positive biological effect in a Corona virus-induced acute lung injury model treated with Apta-1

Aptahem can today announce that in a Corona virus challenge induced Acute Lung Injury model studies with Apta-1 treatment shows strong evidence in maintaining systemic circulation, protection of vital organs, regulation of crucial cytokines and preventing hemolysis.Research commissioned by Aptahem has, with these results, added further understanding to the multifunctional properties of Apta-1 and its broadness to handle pathogen driven inflammatory situations. The results resonating very well with the findings from the collaboration with Örebro University 

CORRECTION to YIT Corporation’s stock exchange release on Interim report January-September 2021 on 29 October 2021 at 9:00 a.m.

YIT Corporation Stock exchange release 29 October 2021 at 9:35 a.m.CORRECTION to YIT Corporation’s stock exchange release on Interim report January-September 2021 on 29 October 2021 at 9:00 a.m. YIT corrects the stock exchange release on Interim report January-September 2021 on 29 October 2021 at 9:00 a.m. In the original stock exchange release, the table was incorrect. Below the release with the correct table. Good profitability progress continued in the third quarter. Group third quarter adjusted operating profit improved to EUR 18 million and more than doubled to EUR 69 million

Atlas Copco raises climate ambitions by setting Science Based Targets

Nacka, Sweden, October 29, 2021: Atlas Copco has set Science Based Targets to reduce greenhouse gas emissions in line with the goals of the Paris Agreement. The Group aims to reduce emissions from its own operations in line with keeping the global temperature rise below 1.5 degrees, and to reduce emissions from the value chain in line with keeping well below a 2-degree temperature rise. The goals are validated by the Science Based Targets initiative.“We are significantly raising our climate ambitions by setting absolute reduction goals for the entire value chain,” said Mats Rahmström,

Azelio publishes white paper with validation data on technical performance of the TES.POD

Azelio’s energy storage test system in Sweden has been gathering an extensive amount of data over a long time. The system performs in all aspects according to the technical performance specification.Azelio’s energy storage system, TES.POD, has been in operation at Azelio’s development centre to gather operational performance data, such as reliability, uptime, nominal power, round-trip-efficiency, storage capacity, and dynamic behaviours to validate the design requirements. The test system performs in all aspects to the technical performance specification. The data has been summarized and

Epiroc speeds up mining electrification with global roll-out of diesel-to-battery conversion for loaders

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, is now offering customers conversion kits that seamlessly transform loaders from diesel-powered to battery-electric driven. The new offering, which has already secured an order in Canada, will speed up the mining industry’s shift to an emissions-free future.Battery conversions are already underway in Canada, with Epiroc’s Scooptram ST1030 loader being the first vehicle to undergo the transformation. Evolution Mining, an Australian-based international mining company,

Change of number of shares and votes in Truecaller AB (publ)

The number of shares and votes in Truecaller AB (publ) (“Truecaller”) has changed during October 2021 as a result of the new share issue and conversion of preference shares in connection with the IPO on 8 October 2021.As of 29 October 2021, the number of shares in Truecaller amounts to 373,664,070, of which 46,783,800 ordinary shares class A with 10 votes per share and 326,880,270 ordinary shares class B with 1 vote per share. In total, the number of votes in Truecaller amounts to 794,718,270. For more information, please contact:  Annika Billberg, Head of IR & Communication+46

Elekta establishes a framework for sustainability-linked bonds

Elekta AB (publ) has established a Sustainability-Linked Bond Framework. Another step in strengthening Elekta’s sustainability focus and emphasis on access to the best cancer care.STOCKHOLM, October 29, 2021 – Elekta (EKTA-B.ST) announced today that it has established a Sustainability-Linked Bond Framework (SLB Framework) for issues of sustainability-linked bonds under its Medium Term Note Program  (MTN-Program). Elekta is among the first companies in Sweden to establish this type of investment framework for bonds. This strengthens

Interim Report 1 July – 30 September 2021

· Strategy updated to include two products targeting 510(k)-approval · Published data from first comparative study and first study with 5-year follow-up from Episealer® · Directed share issue executed, raising SEK 159 million – funding until 2025 secured ”We are currently seeing high activity across the business with several initiatives ongoing within our commercialisation, clinical activities and product development. As already communicated, we experienced certain COVID-19 related effects during the quarter that we cannot disregard, but all in all we are taking important steps in

Interim report Q3, 2021

Third quarter 2021 · Net sales amounted to MSEK 16.2 (4.3) · EBITDA* amounted to MSEK 1,7 (-1.6) · EBIT amounted to MSEK -17.3 (-10.1)  · EBT amounted to MSEK -18.7 (-10.1) · Earnings per share before dilutions amounted to -0.06 (-0.05) · SpectrumOne acquires the mobile surveillance company Observit to be merged with SpectrumOne’s business Trafikportalen with the intention to list and distribute the new company to the shareholders · SpectrumOne has closed acquisition of Observit AB Significant events after the reporting period ·  Preliminary figures show a

Climeon’s nomination committee for the Annual General Meeting 2022

The nomination committee of Climeon AB (publ) for the Annual General Meeting 2022 (AGM) is hereby announced. It consists of the following representatives appointed by the four largest shareholders as per 31 of August 2021, plus the Chairman of the Board: · Thomas Öström, Chairman of the Board, also representing himself (60,02 % of the votes and 16,59 % of the shares as per 31 August 2021) · Joachim Karthäuser, representing himself (11,86 % of the votes and 6,73 % of the shares as per 31 August 2021) · Niklas Johansson, appointed by Handelsbanken Hållbar Energi (1,59 % of the

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 28th October 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,131,695 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Invitation – presentation of Cary Group’s report of the third quarter 2021

Cary Group will publish its third quarter results on Friday, November 12, 2021 at approximately 08:15 AM CEST. A combined webcast and conference call for investors, analysts and financial media will be held at 11:00 AM CEST.The report will be presented by Anders Jensen, CEO, as well as by Joakim Rasiwala, CFO. The presentation will be broadcasted live on our website,www.carygroup.com. Dial-in details for the conference call: SE: +46 8 505 583 56UK: +44 3333 009 273US: +1 631 913 14 22 PIN US: 74641908# For more information, please contact: Helene Gustafsson, Head of IR &

BioStock: Strengthening quarter for Sprint Bioscience

For Sprint Bioscience the third quarter was an intense and news-dense period. Thanks to a licensing agreement and a rights issue, the company now finds itself in its strongest financial position to date and ready to take the next step in its development. BioStock contacted CEO Erik Kinnman to get his view on the past quarter and on the future.Read the full article at biostock.se:https://www.biostock.se/en/2021/10/strengthening-quarter-for-sprint-bioscience/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

There are no items matching the current filter
There are no more items matching the current filter
Back to top